Key Considerations for a Successful EU Orphan Drug Launch

MessageThis Webinar is over
Date Sep 8, 2016
Time 11 am EDT
Cost Free
Online
Launching an orphan drug product onto the European market can present a real challenge if the company is not familiar with country specific requirements. With its 28 member states, numerous official working languages and complex regulatory framework, this webinar will clarify the key requirements for a successful EU product launch.
The speakers in this webinar are experts in navigating market requirements and supporting client partners to successfully launch their orphan drug products into Europe. They have extensive practical experience in the areas of regulatory, quality, packaging design and distribution of launching products into the various EU markets, ensuring launch timelines are met and market entry strategy is successful.
During this interactive webinar, the speakers involved will utilise their experience to guide attendees through the EU orphan drug launch process, from submitting Marketing Authorisation applications to final distribution of drug product to the end-user.

 


comments powered by Disqus
Create your own event
Turn your passion into a business.
Join our mailing list